It is high time that Africa starts evaluating the potential of Point of Care (POC) testing and considers methods via which to embed POC into our health systems. POC technologies offer the opportunity for increased diagnostic capacity in resource limited settings, where there is lack of electricity, technical capacity, reagents, and infrastructure.
In April and August 2021, AHB in partnership with LumiraDx, hosted two discussions on COVID-19 testing in Africa. Key stakeholders represented at the discussions included the Africa CDC, African Society for Laboratory Medicine, Kenya Medical Research Institute (KEMRI), Pathcare Kenya, Meditest Diagnostics Service, Stellenbosch University and Addis Ababa University. The session aimed to set a firm ground on how we can make the diagnostics quicker, better and more cost effective for both NCDs and CDs in Africa, during and beyond the COVID-19 pandemic.